Article
HLA-B15 peptide ligands are preferentially anchored at their C termini.
Journal of immunology (Baltimore, Md. : 1950) - 15 Jun 1999
Prilliman K R, Jackson K W, Lindsey M, Wang J, Crawford D, Hildebrand W H
Abstract excerpt
Therapies to elicit protective CTL require the selection of pathogen- and tumor-derived peptide ligands for presentation by MHC class I molecules. Edman sequencing of class I peptide pools generates "motifs" that indicate that nonameric ligands bearing conserved position 2 (P2) and P9 anchors provide the optimal search parameters for selecting immunogenic epitopes. To determine how well a motif represents its...
Topics
- Alleles
- Amino Acid Sequence
- Antigen Presentation
- Chromatography, High Pressure Liquid
- Conserved Sequence
- Cytosol
- HLA-B Antigens
- HLA-B15 Antigen
- Humans
- Ligands
- Mass Spectrometry
- Models, Molecular
- Molecular Sequence Data
- Peptide Fragments
- Peptide Mapping
